Stockholders Approve Merger of Quinton Cardiology Systems and Cardiac Science
01 September 2005 - 6:22AM
PR Newswire (US)
Merger Expected to Close September 1, 2005 BOTHELL, Wash. and
IRVINE, Calif., Aug. 31 /PRNewswire-FirstCall/ -- Quinton
Cardiology Systems, Inc. (NASDAQ:QUIN), a global leader in advanced
cardiology products, and Cardiac Science, Inc. (NASDAQ:DFIB), a
leading manufacturer of life-saving automatic public-access
defibrillators, announced that the stockholders of both companies
have approved the merger of Quinton Cardiology Systems and Cardiac
Science at their respective special stockholder meetings held
earlier today. The transaction was approved by the holders of a
majority of the shares of each company outstanding as of the record
dates for the special meetings. Approximately 96 percent of the
shares of Cardiac Science common stock cast at the Cardiac Science
special meeting and approximately 97 percent of the shares of
Quinton common stock cast at the Quinton special meeting voted in
favor of the merger proposal. The parties expect to close the
merger on September 1, 2005. This press release includes
forward-looking statements relating to the timing and certainty of
the consummation of the transaction. Quinton and Cardiac Science
have based these forward-looking statements on the current
expectations and beliefs. While Quinton and Cardiac Science believe
these expectations are reasonable, such forward-looking statements
are only predictions and involve known and unknown risks and
uncertainties, many of which are beyond each company's respective
control. These risks include the risk that the transaction may not
be completed on September 1, 2005 as expected. Given these risks
and uncertainties, you are cautioned not to place undue reliance on
such forward-looking statements. Neither Cardiac Science nor
Quinton undertakes any obligation to update any such statements or
to publicly announce the results of any revisions to any such
statements to reflect future events or developments. For Cardiac
Science Investors Matt Clawson (Investors) Len Hall (Media) Allen
& Caron Inc (949) 474-4300 Cardiac Science Roderick de Greef
EVP and CFO (949) 797-3800 Quinton Cardiology Systems Mike Matysik
Sr. Vice President and CFO (425) 402-2009 DATASOURCE: Quinton
Cardiology Systems, Inc.; Cardiac Science, Inc. CONTACT: investors,
Matt Clawson, or media, Len Hall, both of Allen & Caron Inc,
+1-949-474-4300, for Cardiac Science, Inc.; or Roderick de Greef,
EVP and CFO of Cardiac Science, Inc., +1-949-797-3800; or Mike
Matysik, Sr. Vice President and CFO of Quinton Cardiology Systems,
+1-425-402-2009
Copyright
Cardiac Science (NASDAQ:DFIB)
Historical Stock Chart
From Sep 2024 to Oct 2024
Cardiac Science (NASDAQ:DFIB)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Cardiac Science (MM) (NASDAQ): 0 recent articles
More Cardiac Science (MM) News Articles